Please assess the completion status of the following clinical trial:

Trial Title: Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1 -Age older than 18 years of both male and female genders. 2-Individuals diagnosed with PD based on the presence of 2 of 3 cardinal features \& UK bank criteria for idiopathic Parkinson's disease. 3-Patients with motor complications of PD (Hoehn and Yahr stage 2-3)(on therapy) and at least 2 hours off time.~Exclusion Criteria:~1 -Patients with atypical or secondary Parkinsonism syndromes excluding PD. 2-Patients who could not perform the tests. 3-Women who were or might be pregnant, who did not practice effective contraception and were of childbearing potential, or who were breastfeeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients 25 ZNS (Type: ACTIVE_COMPARATOR): 30 patients receive oral 25 mg ZNS daily
- Patients 50 ZNS (Type: ACTIVE_COMPARATOR): 30 patients receive oral 50 mg ZNS daily
- Patients Placebo (Type: PLACEBO_COMPARATOR): 30 patients receive placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).